Press Releases

November 16, 2017 Devonian Announces the Filing of New Patent Application for ThykamineTM

November 09, 2017 Devonian Announces Initiation of Phase IIa Clinical Trial of ThykamineTM in Adult patients with Mild-to-Moderate Atopic Dermatitis

September 28, 2017 Devonian Health Announces PurgenesisTM anti-aging treatment marketing and distribution partnership.

September 14, 2017 Devonian Health Group to present at GCFF (Global Chinese Financial Conference) 18th annual conference

September 06, 2017 Devonian Health Group’s Purgenesis™ anti-aging derma-cosmeceutical treatment is now recognized through the Canadian Dermatology Association Skin Health Program

July 13, 2017 DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES CLOSING OF PRIVATE PLACEMENT

July 07, 2017 DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES GRANT OF OPTIONS

June 22, 2017 DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES PLANS FOR ITS DERMATOLOGY PROGRAM OF THYKAMINE

June 21, 2017 DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES ISSUANCE OF ONE NEW KEY PATENT AND THE GRANTING OF A TRADEMARK

May 31, 2017 DEVONIAN HEALTH GROUP INC.- DEVONIAN ANNOUNCES THE APPOINTMENT OF TWO NEW MEMBERS TO THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT CHANGES TO SUPPORT GROWTH STRATEGY

May 18, 2017 DEVONIAN HEALTH GROUP INC.- LISTING OF ITS SHARES ON THE TSX VENTURE EXCHANGE

May 15, 2017 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC.- COMPLETION OF THE AMALGAMATION AND CLOSING OF A CONCURENT PUBLIC OFFERING

April 27, 2017 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – END OF ITS PREVIOUSLY ANNOUNCED PUBLIC OFFERING

February 03, 2017 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – RECEIPT FOR ITS AMENDED AND RESTATED PROSPECTUS

November 25, 2016 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – RESULTS OF THE VOTES FROM THE ANNUAL GENERAL MEETING OF ORLETTO

November 09, 2016 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – RESULTS OF THE VOTES FROM THE ANNUAL GENERAL MEETING OF DEVONIAN

November 07, 2016 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – DEVONIAN APPOINTS DR JEAN-CLAUDE TARDIF AS CHAIRMAN OF SCIENTIFIC ADVISORY BOARD

August 23, 2016 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – FINANCING BY WAY OF LONG FORM PROSPECTUS

April 26, 2016 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – AGREEMENT IN PRINCIPLE

May 20, 2015 ORLETTO CAPITAL INC. / DEVONIAN HEALTH GROUP INC. – AGREEMENT IN PRINCIPLE